Oscar Health, Inc.

As of June 30, 2026, Oscar Health, Inc. Class A carries a market capitalization of 153.70B, placing it among publicly traded companies globally. Its enterprise value stands at 11.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Oscar Health, Inc. Class A's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Oscar Health, Inc. Class A has 308.63M shares outstanding.

As of June 30, 2026, Oscar Health, Inc. Class A trades at a trailing price-to-earnings ratio of 14.79. The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 4.29.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.04 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Oscar Health, Inc. Class A trades at an EV/FCF ratio of 0.15, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 11.82B versus a market cap of 153.70B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A posted a return on equity (ROE) of 34.31, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 6.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 28.64, useful for judging operating efficiency across full business cycles. The company generates approximately 114.93M in revenue per employee across its workforce of 2,328.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A recorded 679.28M in income tax expense. That works out to an effective tax rate of 6.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 10.30B, leaving 9.62B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Oscar Health, Inc. Class A's stock has gained approximately 62.97% over the past 52 weeks. The 50-day moving average sits at 557.89, while the 200-day moving average is 406.95.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A generated 267.64B in revenue and converted that into 9.62B in net income, yielding earnings per share of 31.93.

As of June 30, 2026, Oscar Health, Inc. Class A holds 149.48B in cash and equivalents against 7.54B in total debt, resulting in a net debt position of -63.67B.

Oscar Health, Inc. Class A produced 77.20B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -674.84M in capital expenditures, free cash flow totaled 76.52B - equivalent to 267.82 per share.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 50.98, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -4.34, meaning Oscar Health, Inc. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.